Пређи на садржај

Кардиоторакална и васкуларна хирургија

Антикоагулантна терапија и реверзија антикоагулантног ефекта

Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal. A systematic review and meta-analysis. (отвара нови прозор)

Chai-Adisaksopha C, Hillis C, Siegal DM, Movilla R, Heddle N, Iorio A, Crowther M.

Извор‎: Thromb Haemost 2016;116(5):879-90.

Индекс‎: PubMed 27488143

DOI‎: 10.1160/TH16-04-0266

https://www.ncbi.nlm.nih.gov/pubmed/27488143 (отвара нови прозор)

Reversal of warfarin: case-based practice recommendations. (отвара нови прозор)

Garcia DA, Crowther MA.

Извор‎: Circulation 2012;125(23):2944-7.

Индекс‎: PubMed 22689931

DOI‎: 10.1161/CIRCULATIONAHA.111.081489

https://www.ncbi.nlm.nih.gov/pubmed/22689931 (отвара нови прозор)

Stopping antiplatelet medication before coronary artery bypass graft surgery: is there an optimal timing to minimize bleeding? (отвара нови прозор)

Gielen CL, Bruggemans EF, Stijnen T, Eikenboom J, Tavilla G, Brand A, Klautz RJ.

Извор‎: Eur J Cardiothorac Surg 2015;48(4):e64-70.

Индекс‎: PubMed 26248820

DOI‎: 10.1093/ejcts/ezv269

https://www.ncbi.nlm.nih.gov/pubmed/26248820 (отвара нови прозор)

Is a fully heparin-bonded cardiopulmonary bypass circuit superior to a standard cardiopulmonary bypass circuit? (отвара нови прозор)

Mahmood S, Bilal H, Zaman M, Tang A.

Извор‎: Interact Cardiovasc Thorac Surg 2012;14(4):406-14.

Индекс‎: PubMed 22228288

DOI‎: 10.1093/icvts/ivr124

https://www.ncbi.nlm.nih.gov/pubmed/22228288 (отвара нови прозор)

Heparin-bonded circuits versus nonheparin-bonded circuits: an evaluation of their effect on clinical outcomes. (отвара нови прозор)

Mangoush O, Purkayastha S, Haj-Yahia S, Kinross J, Hayward M, Bartolozzi F, Darzi A, Athanasiou T.

Извор‎: Eur J Cardiothorac Surg 2007;31(6):1058-69.

Индекс‎: PubMed 17306555

DOI‎: 10.1016/j.ejcts.2007.01.029

https://www.ncbi.nlm.nih.gov/pubmed/17306555 (отвара нови прозор)

Idarucizumab for dabigatran reversal. (отвара нови прозор)

Pollack CV Jr, Reilly PA, Eikelboom J, Glund S, Verhamme P, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kamphuisen PW, Kreuzer J, Levy JH, Sellke FW, Stangier J, Steiner T, Wang B, Kam CW, Weitz JI.

Извор‎: N Engl J Med 2015;373(6):511-20.

Индекс‎: PubMed 26095746

DOI‎: 10.1056/NEJMoa1502000

https://www.ncbi.nlm.nih.gov/pubmed/26095746 (отвара нови прозор)

Idarucizumab for dabigatran reversal - full cohort analysis. (отвара нови прозор)

Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kam CW, Kamphuisen PW, Kreuzer J, Levy JH, Royle G, Sellke FW, Stangier J, Steiner T, Verhamme P, Wang B, Young L, Weitz JI

Извор‎: N Engl J Med 2017;377(5):431-41.

Индекс‎: PubMed 28693366

DOI‎: 10.1056/NEJMoa1707278

https://www.ncbi.nlm.nih.gov/pubmed/28693366 (отвара нови прозор)

Platelet mapping and desmopressin reversal of platelet inhibition during emergency carotid endarterectomy. (отвара нови прозор)

Ranucci M, Nano G, Pazzaglia A, Bianchi P, Casana R, Tealdi DG.

Извор‎: J Cardiothorac Vasc Anesth 2007;21(6):851-4.

Индекс‎: PubMed 18068065

DOI‎: 10.1053/j.jvca.2007.05.009

https://www.ncbi.nlm.nih.gov/pubmed/18068065 (отвара нови прозор)

Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study. (отвара нови прозор)

Sarode R, Milling TJ Jr, Refaai MA, Mangione A, Schneider A, Durn BL, Goldstein JN.

Извор‎: Circulation 2013;128(11):1234-43.

Индекс‎: PubMed 23935011

DOI‎: 10.1161/CIRCULATIONAHA.113.002283

https://www.ncbi.nlm.nih.gov/pubmed/23935011 (отвара нови прозор)

Protective effects of tranexamic acid on clopidogrel before coronary artery bypass grafting: a multicenter randomized trial. (отвара нови прозор)

Shi J, Ji H, Ren F, Wang G, Xu M, Xue Y, Chen M, Qi J, Li L.

Извор‎: JAMA Surg 2013;148(6):538-47.

Индекс‎: PubMed 23426385

DOI‎: 10.1001/jamasurg.2013.1560

https://www.ncbi.nlm.nih.gov/pubmed/23426385 (отвара нови прозор)

Andexanet alfa for the reversal of Factor Xa inhibitor activity. (отвара нови прозор)

Siegal DM, Curnutte JT, Connolly SJ, Lu G, Conley PB, Wiens BL, Mathur VS, Castillo J, Bronson MD, Leeds JM, Mar FA, Gold A, Crowther MA.

Извор‎: N Engl J Med 2015;373(25):2413-24.

Индекс‎: PubMed 26559317

DOI‎: 10.1056/NEJMoa1510991

https://www.ncbi.nlm.nih.gov/pubmed/26559317 (отвара нови прозор)

Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding. (отвара нови прозор)

Warkentin TE, Margetts P, Connolly SJ, Lamy A, Ricci C, Eikelboom JW.

Извор‎: Blood 2012;119(9):2172-4.

Индекс‎: PubMed 22383791

DOI‎: 10.1182/blood-2011-11-393587

https://www.ncbi.nlm.nih.gov/pubmed/22383791 (отвара нови прозор)

Heparinized cardiopulmonary bypass circuits and low systemic anticoagulation: an analysis of nearly 6000 patients undergoing coronary artery bypass grafting. (отвара нови прозор)

Øvrum E, Tangen G, Tølløfsrud S, Skeie B, Ringdal MA, Istad R, Øystese R.

Извор‎: J Thorac Cardiovasc Surg 2011;141(5):1145-9.

Индекс‎: PubMed 20709334

DOI‎: 10.1016/j.jtcvs.2010.07.003

https://www.ncbi.nlm.nih.gov/pubmed/20709334 (отвара нови прозор)